Long-term care pharmacies and clinicians have temporarily paused their use of Johnson & Johnson’s COVID vaccine following recommendations from health officials. Guidance is needed quickly in order to keep residents safe, they say.
Long-term care pharmacies have stopped using the Johnson & Johnson COVID-19 vaccine and are awaiting further instruction from federal health officials, who recommended the halt while they investigate six reports of rare and serious blood clots in people who received it.
COVID-19 monoclonal antibodies are now widely available for use by skilled nursing facilities — and early results show promise, according to long-term care pharmacy leaders.
With vaccine approval anticipated shortly, the best communicators will have the smoothest Phase 1 vaccination process, say Omnicare and PharMerica. Community pharmacies have recommendations as well.
The collaboration will add manpower, reporting and other key capabilities to future COVID vaccine delivery in LTC facilities and communities, says Griffin, an Operation Warp Speed adviser.
Some long-term care stakeholders might question parts of the new federal-private partnership that ultimately will offer COVID-19 vaccination materials to every certified nursing home in the nation.
Long-term care pharmacies now have a voice in federal decisions about COVID vaccine delivery to nursing homes and assisted living communities, says the American Society of Consultant Pharmacists.
Got a lot on your plate? We get it. The deadline to submit nominations has been extended to Wednesday, Jan. 15.
Nominations for the 2020 McKnight’s Women of Distinction awards are due by midnight tonight.
BrightSpring Health Services and PharMerica Corporation have announced they are combining forces.
